Shares of Oxford Biomedica plc (LON:OXB – Get Free Report) crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of GBX 420.59 ($5.29) and traded as high as GBX 426 ($5.36). Oxford Biomedica shares last traded at GBX 421.50 ($5.30), with a volume of 43,576 shares trading hands.
Analysts Set New Price Targets
Separately, Deutsche Bank Aktiengesellschaft raised their target price on shares of Oxford Biomedica from GBX 250 ($3.15) to GBX 380 ($4.78) and gave the stock a “hold” rating in a report on Tuesday, September 24th.
View Our Latest Stock Analysis on OXB
Oxford Biomedica Stock Performance
About Oxford Biomedica
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
Recommended Stories
- Five stocks we like better than Oxford Biomedica
- ETF Screener: Uses and Step-by-Step Guide
- S&P 500 ETFs: Expense Ratios That Can Boost Your Long-Term Gains
- The Basics of Support and Resistance
- How AI Implementation Could Help MongoDB Roar Back in 2025
- What Are Dividend Challengers?
- Hedge Funds Boost Oil Positions: Is a Major Rally on the Horizon?
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.